GC
CORZ icon

Gullane Capital’s Core Scientific CORZ Stock Holding History

Gullane Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.3M Sell
2,162,036
-176,813
-8% -$4.16M 93.41% 1
2026
Q1 		$35M Sell
2,338,849
-76,259
-3% -$1.3M 93.61% 1
2025
Q4 		$35.2M Sell
2,415,108
-880,871
-27% -$15.4M 94.14% 1
2025
Q3 		$59.1M Sell
3,295,979
-7,028,794
-68% -$103M 94.33% 1
2025
Q2 		$176M Buy
10,324,773
+285,897
+3% +$2.86M 93.61% 1
2025
Q1 		$72.7M Sell
10,038,876
-2,381,319
-19% -$27.1M 91.02% 1
2024
Q4 		$175M Buy
+12,420,195
New +$183M 76.75% 1

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Gullane Capital's CORZ Position: Q2 2026 in Review

Gullane Capital reduced its Core Scientific (CORZ) stake by 7.6% in Q2 2026, selling an estimated $4.16M and leaving 2,162,036 shares worth $55.3M. The position accounts for 93.41% of the portfolio, ranked #1.

Gullane Capital first reported a position in CORZ in Q4 2024 and has held it in 7 quarters since. The position peaked at $176M in Q2 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Gullane Capital held 2,162,036 shares of Core Scientific worth $55.3M as of Q2 2026.
  • Gullane Capital sold 176,813 Core Scientific shares in Q2 2026, an estimated $4.16M.
  • Core Scientific made up 93.41% of Gullane Capital's portfolio in Q2 2026, its #1 holding.
  • Gullane Capital first reported a position in Core Scientific in Q4 2024 and has held it in 7 quarters since.
  • Gullane Capital's Core Scientific position peaked at $176M in Q2 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Gullane Capital's 13F filing for Q2 2026, filed 13 Aug 2026.